Nature, Published online: 10 May 2023; doi:10.1038/d41586-023-01526-8Efforts to tackle pancreatic cancer by harnessing immune cells have had limited success. A clinical trial reports promising results from testing a personalized approach to boosting immune responses to such tumours.